 | • レポートコード：QYR9ST03915 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、低カルシウム血症治療の世界市場について調査・分析し、低カルシウム血症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（無症候性、症候性、予防）、用途別（病院、診療所、研究所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の低カルシウム血症治療市場動向 ・主要企業別マーケットシェア ・低カルシウム血症治療の種類別市場規模2014-2019 （無症候性、症候性、予防） ・低カルシウム血症治療の用途別市場規模2014-2019 （病院、診療所、研究所） ・低カルシウム血症治療の北米市場：主要企業・種類別/用途別市場規模 ・低カルシウム血症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・低カルシウム血症治療の中国市場：主要企業・種類別/用途別市場規模 ・低カルシウム血症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・低カルシウム血症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・低カルシウム血症治療のインド市場：主要企業・種類別/用途別市場規模 ・低カルシウム血症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （F. Hoffman La Roche、Novo Nordisk、Sanofi、GlaxoSmithKline (GSK)、Pfizer Inc.、Ranbaxy Pharmaceuticals Ltd.） ・低カルシウム血症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Hypocalcaemia is imbalance of electrolytes which is indicated by abnormally low level of calcium in the body. A healthy person has 8.5-10.2 mg/dL calcium level in his/her body, however, drop in this level could possibly led to hypocalcaemia disorder. Middle aged population needs to take 1000 mg of calcium while geriatrics population aged 65 and above should take 1500 mg of calcium per day. Hypocalcaemia is caused by hypoalbuminemia, hyperphosphatemia, surgical effects, medication effects, hypomagnesemia, heart failure, muscle cramps, vitamin D deficiency, alcoholism, magnesium deficiency, insufficient protein in the blood, in the blood and many more. Neuromuscular irritability is the most common sign of hypocalcaemia. Hypocalcaemia are mostly diagnosed by clinical suspicion and laboratory testing. Hypoparathyroidism has a major effect on hypocalcaemia and high recurrence rate.In 2018, the global Hypocalcaemia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hypocalcaemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypocalcaemia Treatment development in United States, Europe and China.
The key players covered in this study
F. Hoffman La Roche
Novo Nordisk
Sanofi
GlaxoSmithKline (GSK)
Pfizer Inc.
Ranbaxy Pharmaceuticals Ltd.
…
Market segment by Type, the product can be split into
Asymptomatic
Symptomatic
Prophylactic
Market segment by Application, split into
Hosptial
Clinic
Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hypocalcaemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Hypocalcaemia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hypocalcaemia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hypocalcaemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Asymptomatic
1.4.3 Symptomatic
1.4.4 Prophylactic
1.5 Market by Application
1.5.1 Global Hypocalcaemia Treatment Market Share by Application (2014-2025)
1.5.2 Hosptial
1.5.3 Clinic
1.5.4 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hypocalcaemia Treatment Market Size
2.2 Hypocalcaemia Treatment Growth Trends by Regions
2.2.1 Hypocalcaemia Treatment Market Size by Regions (2014-2025)
2.2.2 Hypocalcaemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hypocalcaemia Treatment Market Size by Manufacturers
3.1.1 Global Hypocalcaemia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Hypocalcaemia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hypocalcaemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Hypocalcaemia Treatment Key Players Head office and Area Served
3.3 Key Players Hypocalcaemia Treatment Product/Solution/Service
3.4 Date of Enter into Hypocalcaemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hypocalcaemia Treatment Market Size by Type (2014-2019)
4.2 Global Hypocalcaemia Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Hypocalcaemia Treatment Market Size (2014-2019)
5.2 Hypocalcaemia Treatment Key Players in United States
5.3 United States Hypocalcaemia Treatment Market Size by Type
5.4 United States Hypocalcaemia Treatment Market Size by Application
6 Europe
6.1 Europe Hypocalcaemia Treatment Market Size (2014-2019)
6.2 Hypocalcaemia Treatment Key Players in Europe
6.3 Europe Hypocalcaemia Treatment Market Size by Type
6.4 Europe Hypocalcaemia Treatment Market Size by Application
7 China
7.1 China Hypocalcaemia Treatment Market Size (2014-2019)
7.2 Hypocalcaemia Treatment Key Players in China
7.3 China Hypocalcaemia Treatment Market Size by Type
7.4 China Hypocalcaemia Treatment Market Size by Application
8 Japan
8.1 Japan Hypocalcaemia Treatment Market Size (2014-2019)
8.2 Hypocalcaemia Treatment Key Players in Japan
8.3 Japan Hypocalcaemia Treatment Market Size by Type
8.4 Japan Hypocalcaemia Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hypocalcaemia Treatment Market Size (2014-2019)
9.2 Hypocalcaemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Hypocalcaemia Treatment Market Size by Type
9.4 Southeast Asia Hypocalcaemia Treatment Market Size by Application
10 India
10.1 India Hypocalcaemia Treatment Market Size (2014-2019)
10.2 Hypocalcaemia Treatment Key Players in India
10.3 India Hypocalcaemia Treatment Market Size by Type
10.4 India Hypocalcaemia Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Hypocalcaemia Treatment Market Size (2014-2019)
11.2 Hypocalcaemia Treatment Key Players in Central & South America
11.3 Central & South America Hypocalcaemia Treatment Market Size by Type
11.4 Central & South America Hypocalcaemia Treatment Market Size by Application
12 International Players Profiles
12.1 F. Hoffman La Roche
12.1.1 F. Hoffman La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hypocalcaemia Treatment Introduction
12.1.4 F. Hoffman La Roche Revenue in Hypocalcaemia Treatment Business (2014-2019)
12.1.5 F. Hoffman La Roche Recent Development
12.2 Novo Nordisk
12.2.1 Novo Nordisk Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hypocalcaemia Treatment Introduction
12.2.4 Novo Nordisk Revenue in Hypocalcaemia Treatment Business (2014-2019)
12.2.5 Novo Nordisk Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hypocalcaemia Treatment Introduction
12.3.4 Sanofi Revenue in Hypocalcaemia Treatment Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 GlaxoSmithKline (GSK)
12.4.1 GlaxoSmithKline (GSK) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hypocalcaemia Treatment Introduction
12.4.4 GlaxoSmithKline (GSK) Revenue in Hypocalcaemia Treatment Business (2014-2019)
12.4.5 GlaxoSmithKline (GSK) Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hypocalcaemia Treatment Introduction
12.5.4 Pfizer Inc. Revenue in Hypocalcaemia Treatment Business (2014-2019)
12.5.5 Pfizer Inc. Recent Development
12.6 Ranbaxy Pharmaceuticals Ltd.
12.6.1 Ranbaxy Pharmaceuticals Ltd. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hypocalcaemia Treatment Introduction
12.6.4 Ranbaxy Pharmaceuticals Ltd. Revenue in Hypocalcaemia Treatment Business (2014-2019)
12.6.5 Ranbaxy Pharmaceuticals Ltd. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hypocalcaemia Treatment Key Market Segments
Table Key Players Hypocalcaemia Treatment Covered
Table Global Hypocalcaemia Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hypocalcaemia Treatment Market Size Market Share by Type 2014-2025
Figure Asymptomatic Figures
Table Key Players of Asymptomatic
Figure Symptomatic Figures
Table Key Players of Symptomatic
Figure Prophylactic Figures
Table Key Players of Prophylactic
Table Global Hypocalcaemia Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hosptial Case Studies
Figure Clinic Case Studies
Figure Research Case Studies
Figure Hypocalcaemia Treatment Report Years Considered
Table Global Hypocalcaemia Treatment Market Size 2014-2025 (Million US$)
Figure Global Hypocalcaemia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hypocalcaemia Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Hypocalcaemia Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Hypocalcaemia Treatment Market Share by Regions 2014-2019
Figure Global Hypocalcaemia Treatment Market Share by Regions 2014-2019
Figure Global Hypocalcaemia Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Hypocalcaemia Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hypocalcaemia Treatment Market Share by Manufacturers (2014-2019)
Figure Global Hypocalcaemia Treatment Market Share by Manufacturers in 2018
Table Global Hypocalcaemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hypocalcaemia Treatment Product/Solution/Service
Table Date of Enter into Hypocalcaemia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hypocalcaemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Hypocalcaemia Treatment Market Size Share by Type (2014-2019)
Figure Global Hypocalcaemia Treatment Market Size Market Share by Type (2014-2019)
Table Global Hypocalcaemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Hypocalcaemia Treatment Market Size Share by Application (2014-2019)
Figure Global Hypocalcaemia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Hypocalcaemia Treatment Revenue Market Share by Application in 2018
Figure United States Hypocalcaemia Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Hypocalcaemia Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Hypocalcaemia Treatment Market Share (2018-2019)
Table United States Hypocalcaemia Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Hypocalcaemia Treatment Market Share by Type (2014-2019)
Table United States Hypocalcaemia Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Hypocalcaemia Treatment Market Share by Application (2014-2019)
Figure Europe Hypocalcaemia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Hypocalcaemia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Hypocalcaemia Treatment Market Share (2018-2019)
Table Europe Hypocalcaemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Hypocalcaemia Treatment Market Share by Type (2014-2019)
Table Europe Hypocalcaemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Hypocalcaemia Treatment Market Share by Application (2014-2019)
Figure China Hypocalcaemia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Hypocalcaemia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Hypocalcaemia Treatment Market Share (2018-2019)
Table China Hypocalcaemia Treatment Market Size by Type (2014-20189) (Million US$)
Table China Hypocalcaemia Treatment Market Share by Type (2014-2019)
Table China Hypocalcaemia Treatment Market Size by Application (2014-2019) (Million US$)
Table China Hypocalcaemia Treatment Market Share by Application (2014-2019)
Figure Japan Hypocalcaemia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Hypocalcaemia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Hypocalcaemia Treatment Market Share (2018-2019)
Table Japan Hypocalcaemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Hypocalcaemia Treatment Market Share by Type (2014-2019)
Table Japan Hypocalcaemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Hypocalcaemia Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Hypocalcaemia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hypocalcaemia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hypocalcaemia Treatment Market Share (2018-2019)
Table Southeast Asia Hypocalcaemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hypocalcaemia Treatment Market Share by Type (2014-2019)
Table Southeast Asia Hypocalcaemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hypocalcaemia Treatment Market Share by Application (2014-2019)
Figure India Hypocalcaemia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Hypocalcaemia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Hypocalcaemia Treatment Market Share (2018-2019)
Table India Hypocalcaemia Treatment Market Size by Type (2014-2019) (Million US$)
Table India Hypocalcaemia Treatment Market Share by Type (2014-2019)
Table India Hypocalcaemia Treatment Market Size by Application (2014-2019) (Million US$)
Table India Hypocalcaemia Treatment Market Share by Application (2014-2019)
Figure Central & South America Hypocalcaemia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hypocalcaemia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hypocalcaemia Treatment Market Share (2018-2019)
Table Central & South America Hypocalcaemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hypocalcaemia Treatment Market Share by Type (2014-2019)
Table Central & South America Hypocalcaemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hypocalcaemia Treatment Market Share by Application (2014-2019)
Table F. Hoffman La Roche Company Details
Table F. Hoffman La Roche Revenue in Hypocalcaemia Treatment Business (2014-2019) (Million US$)
Figure F. Hoffman La Roche Revenue Growth Rate in Hypocalcaemia Treatment Business (2014-2019)
Table F. Hoffman La Roche Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Hypocalcaemia Treatment Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Hypocalcaemia Treatment Business (2014-2019)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Hypocalcaemia Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Hypocalcaemia Treatment Business (2014-2019)
Table Sanofi Recent Development
Table GlaxoSmithKline (GSK) Company Details
Table GlaxoSmithKline (GSK) Revenue in Hypocalcaemia Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline (GSK) Revenue Growth Rate in Hypocalcaemia Treatment Business (2014-2019)
Table GlaxoSmithKline (GSK) Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Hypocalcaemia Treatment Business (2014-2019)(Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Hypocalcaemia Treatment Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Ranbaxy Pharmaceuticals Ltd. Company Details
Table Ranbaxy Pharmaceuticals Ltd. Revenue in Hypocalcaemia Treatment Business (2014-2019)(Million US$)
Figure Ranbaxy Pharmaceuticals Ltd. Revenue Growth Rate in Hypocalcaemia Treatment Business (2014-2019)
Table Ranbaxy Pharmaceuticals Ltd. Recent Development
Table Global Hypocalcaemia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Hypocalcaemia Treatment Market Size Share by Regions (2019-2025)
Figure Global Hypocalcaemia Treatment Market Size Share by Regions in 2025
Figure United States Hypocalcaemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hypocalcaemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Hypocalcaemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hypocalcaemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hypocalcaemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Hypocalcaemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hypocalcaemia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Hypocalcaemia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Hypocalcaemia Treatment Market Size by Product (2019-2025)
Figure Global Hypocalcaemia Treatment Market Size by Product in 2025
Table Global Hypocalcaemia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Hypocalcaemia Treatment Market Size by Application (2019-2025)
Figure Global Hypocalcaemia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
HER2陰性乳癌治療の世界市場：市場規模・現状・予測 HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein.In 2018, the global HER2-negative breast cancer Treatment mar…- 慢性骨髄性白血病治療の世界市場：市場規模・現状・予測 Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow.In 2018, the global Chronic Myelogenous Leukemia Treatment market size was xx million US$ and it is expected to reach xx million US$ by th…
- 超音波による本態性振戦治療の世界市場：市場規模・現状・予測 Essential tremors are involuntary trembling in one or more parts of body. Essential tremors treatment with ultrasound market is supposed to be driven by factors such as increase in age related neurological disorder. FDA approvals for clinical trials and huge inflow of new players entering the market…
- 統合失調感情障害治療の世界市場：市場規模・現状・予測 Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders.The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. In 2018, the global Schizoaffective Disorders Treatment market size was xx million …
- 巨細胞性動脈炎治療の世界市場：市場規模・現状・予測 Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin h…